Patterns of synthetic cannabinoid use in Australia

Introduction and Aims. To assess the demographic profile, use patterns, market characteristics, reasons for first use and self-reported harms associated with use of synthetic cannabinoids in Australia. Design and Methods. An online questionnaire was administered to a purposive sample of 316 Australi...

Full description

Bibliographic Details
Main Authors: Barratt, Monica, Cakic, V., Lenton, Simon
Format: Journal Article
Published: Wiley-Blackwell Publishing Ltd. 2012
Subjects:
Online Access:http://hdl.handle.net/20.500.11937/11444
_version_ 1848747806928404480
author Barratt, Monica
Cakic, V.
Lenton, Simon
author_facet Barratt, Monica
Cakic, V.
Lenton, Simon
author_sort Barratt, Monica
building Curtin Institutional Repository
collection Online Access
description Introduction and Aims. To assess the demographic profile, use patterns, market characteristics, reasons for first use and self-reported harms associated with use of synthetic cannabinoids in Australia. Design and Methods. An online questionnaire was administered to a purposive sample of 316 Australian synthetic cannabinoid users [96% cannabis users,77% male, median age 27 years, interquartile range (IQR) 23–34] who self-reported demographic and drug use characteristics. Results. The median duration of synthetic cannabinoid use was 6 months (IQR 2–10),35% reported use weekly or more often and 7% reported daily use. Reasons for first use included curiosity (50%), legality (39%), availability (23%), recreational effects (20%), therapeutic effects (9%), non-detection in standard drug screening assays (8%) and to aid the reduction or cessation of cannabis use (5%). Users reported buying a median of 3 g (IQR 3–6) and paying a median of AU$60 (IQR 37–90). Most (68%) reported at least one side-effect during their last session of use, including decreased motor co-ordination (39%), fast or irregular heartbeat (33%), dissociation (22%), dizziness (20%), paranoia (18%) and psychosis (4%). 4 respondents reported seeking help. A greater number of side-effects were reported by males, those aged 18–25 years, water pipe (‘bong’) users and concurrent alcohol drinkers. Discussion and Conclusions. The sample reported first using synthetic cannabinoids due to curiosity, legality, availability, effects, non-detection in drug testing and to reduce their cannabis use.Harms were widely reported yet help-seeking was minimal. Inclusion of questions regarding synthetic cannabinoids in household surveys is warranted.
first_indexed 2025-11-14T06:55:00Z
format Journal Article
id curtin-20.500.11937-11444
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T06:55:00Z
publishDate 2012
publisher Wiley-Blackwell Publishing Ltd.
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-114442017-09-13T15:54:08Z Patterns of synthetic cannabinoid use in Australia Barratt, Monica Cakic, V. Lenton, Simon demography cannabinoids cannabis questionnaire prevalence Introduction and Aims. To assess the demographic profile, use patterns, market characteristics, reasons for first use and self-reported harms associated with use of synthetic cannabinoids in Australia. Design and Methods. An online questionnaire was administered to a purposive sample of 316 Australian synthetic cannabinoid users [96% cannabis users,77% male, median age 27 years, interquartile range (IQR) 23–34] who self-reported demographic and drug use characteristics. Results. The median duration of synthetic cannabinoid use was 6 months (IQR 2–10),35% reported use weekly or more often and 7% reported daily use. Reasons for first use included curiosity (50%), legality (39%), availability (23%), recreational effects (20%), therapeutic effects (9%), non-detection in standard drug screening assays (8%) and to aid the reduction or cessation of cannabis use (5%). Users reported buying a median of 3 g (IQR 3–6) and paying a median of AU$60 (IQR 37–90). Most (68%) reported at least one side-effect during their last session of use, including decreased motor co-ordination (39%), fast or irregular heartbeat (33%), dissociation (22%), dizziness (20%), paranoia (18%) and psychosis (4%). 4 respondents reported seeking help. A greater number of side-effects were reported by males, those aged 18–25 years, water pipe (‘bong’) users and concurrent alcohol drinkers. Discussion and Conclusions. The sample reported first using synthetic cannabinoids due to curiosity, legality, availability, effects, non-detection in drug testing and to reduce their cannabis use.Harms were widely reported yet help-seeking was minimal. Inclusion of questions regarding synthetic cannabinoids in household surveys is warranted. 2012 Journal Article http://hdl.handle.net/20.500.11937/11444 10.1111/j.1465-3362.2012.00519.x Wiley-Blackwell Publishing Ltd. unknown
spellingShingle demography
cannabinoids
cannabis
questionnaire
prevalence
Barratt, Monica
Cakic, V.
Lenton, Simon
Patterns of synthetic cannabinoid use in Australia
title Patterns of synthetic cannabinoid use in Australia
title_full Patterns of synthetic cannabinoid use in Australia
title_fullStr Patterns of synthetic cannabinoid use in Australia
title_full_unstemmed Patterns of synthetic cannabinoid use in Australia
title_short Patterns of synthetic cannabinoid use in Australia
title_sort patterns of synthetic cannabinoid use in australia
topic demography
cannabinoids
cannabis
questionnaire
prevalence
url http://hdl.handle.net/20.500.11937/11444